Kaitlyn Bader is a journalist who specializes in dermatology and healthcare topics. She writes for Dermatology Times and her work has also been featured in AJMC - The American Journal of Managed Care and Drug Topics. Kaitlyn's articles cover a range of subjects including new treatments, clinical trials, industry news, and conference recaps in the field of dermatology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Kaitlyn Bader's coverage focuses on healthcare, pharmaceuticals, and scientific developments within the field of dermatology. She regularly cites data and includes expert commentary, indicating a preference for evidence-based insights from professionals in the medical and pharmaceutical fields.
Given her focus on specific medical conditions, drug trials, and research breakthroughs in dermatology, Kaitlyn would likely value pitches that offer access to experts directly involved in the research or development of treatments for skin conditions. Additionally, she might be interested in interviews with clinicians who have extensive experience treating these conditions or researchers with unique findings related to dermatological issues.
As geographic focus is not specified but given the nature of medical research being global by default unless stated otherwise; consider offering international perspectives or examples when pitching relevant stories to Kaitlyn.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Learn more about the in-depth topics covered in the October 2024 print issue of Dermatology Times.
By: Kaitlyn Bader, Christopher G. Bunick
Christopher Bunick, MD, PhD, highlights rademikibart's next-generation efficacy, showing stronger IL-4Rα binding affinity in atopic dermatitis and asthma.
Learn more about the in-depth topics covered in the October 2024 vitiligo supplement of Dermatology Times.
Learn more about the in-depth topics covered in the October 2024 acne supplement of Dermatology Times.
By: Steve Xu, Kaitlyn Bader
As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and the consideration of safer acne treatment alternatives.
By: Renata Block, Kaitlyn Bader
Bree Vanleeuwen, PA-C, and Jim Sutton, PA-C, discussed the Skin Cancer Awareness project—a unique initiative to train cosmetologists and hairdressers to recognize suspicious skin lesions and refer clients for dermatologic evaluation.
Block emphasized the importance of breakout sessions geared toward varying levels of experience—beginner, intermediate, and advanced.
The conference aimed at providing physician assistants with the latest in dermatology advancements begins today in Las Vegas, Nevada.
Share with us the topics you want to learn more about at SDPA Fall.
Catch up on coverage from the first day of the 2024 Fall Society of Dermatology Physician Associates Conference in Las Vegas, Nevada.
(833) 317-6278 
